BRIEF-Acadia's Nuplazid available for treatment of hallucinations, delusions associated with Parkinson's

* Nuplazid (pimavanserin) now available for treatment of hallucinations and delusions associated with Parkinson's disease psychosis Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.